Revenue
2.07 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 2067212 USD Source
Fundies. English
HEALTHY EXTRACTS INC.
EDGARAnnual consolidated revenue for 2025: about USD 4.512M, using the latest reported figures. The previous period, 2024, was about USD 3.113M.
Latest quarter
- Cash and cash equivalents
- 113 thousand USD Source
Exact value
112918 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 14.7 million shares Source
Exact value
14741348 shares
Reported share-count change
369.25% · 11.6 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
6.29 million USD
2025-07-01 – 2026-06-30
Net income
-879 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Capital expenditure
0 USD
2023-07-01 – 2024-06-30
Exact inputs and evidence
- Capital expenditure: 0 USD · 2023-01-01 – 2023-09-30 Source
- Capital expenditure: 0 USD · 2023-01-01 – 2023-06-30 Source
- Capital expenditure: 0 USD · 2023-01-01 – 2023-12-31 Source
- Capital expenditure: 0 USD · 2023-01-01 – 2023-09-30 Source
- Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
- Capital expenditure: 0 USD · 2024-01-01 – 2024-06-30 Source
- Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-14.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2025-12-31
- Operating income: 4 of 11 periods available· newest 2018-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- Capital expenditure: 5 of 11 periods available· newest 2023-12-31
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 8 of 11 periods available· newest 2025-12-31
- Current assets: 11 of 11 periods available· newest 2025-12-31
- Current liabilities: 11 of 11 periods available· newest 2025-12-31
- cash and cash equivalents: No compatible figures in this window
- long term debt: No compatible figures in this window
- Shares outstanding: 11 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+44.9%Prior period
USD 3.11 million
–
Current period
USD 4.51 million
–
Exact inputs and evidence
4511997 − 3113279 = 1398718 USD
3113279 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source4511997 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 40,448Prior period
−USD 840,671
–
Current period
−USD 881,119
–
Exact inputs and evidence
-881119 − -840671 = -40448 USD
-840671 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-881119 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-41.3%Prior period
USD 281,968
–
Current period
USD 165,520
–
Exact inputs and evidence
165520 − 281968 = -116448 USD
281968 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source165520 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 4.51 million 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income −USD 881,119 −20% of revenue
Cash
- Operating cash flow USD 165,520 3.7% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Operating loss: operating costs were 48,012% of revenue.
- 2018 Operating loss: operating costs were 5,050% of revenue.
- 2019 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Not shown: operating income or net income is not reported.
- 2023 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
- 2025 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | 7605 | 3651293 Derived | -3643688 | -81613 Derived | -3562075 | Unavailable | Source
|
| 2018 2018-01-01 – 2018-12-31 | 67131 | 3390390 Derived | -3323259 | 6258 Derived | -3329517 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 748377 | Unavailable | Unavailable | Unavailable | 632776 | -1753773 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 1299398 | Unavailable | Unavailable | Unavailable | -2576375 | -1902758 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 1676598 | Unavailable | Unavailable | Unavailable | -1987122 | -901298 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 2251469 | Unavailable | Unavailable | Unavailable | -983121 | -398608 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 2485866 | Unavailable | Unavailable | Unavailable | -2472931 | -415749 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 3113279 | Unavailable | Unavailable | Unavailable | -840671 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 4511997 | Unavailable | Unavailable | Unavailable | -881119 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 4.5M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 162750 |
|
| 2017 | Revenue | 7605 |
|
| 2018 | Revenue | 67131 |
|
| 2019 | Revenue | 748377 |
|
| 2020 | Revenue | 1299398 |
|
| 2021 | Revenue | 1676598 |
|
| 2022 | Revenue | 2251469 |
|
| 2023 | Revenue | 2485866 |
|
| 2024 | Revenue | 3113279 |
|
| 2025 | Revenue | 4511997 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
44.9% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | 40.8% |
|
| 2017 | Year over year | -95.3% |
|
| 2018 | Year over year | 782.7% |
|
| 2019 | Year over year | 1,014.8% |
|
| 2020 | Year over year | 73.6% |
|
| 2021 | Year over year | 29% |
|
| 2022 | Year over year | 34.3% |
|
| 2023 | Year over year | 10.4% |
|
| 2024 | Year over year | 25.2% |
|
| 2025 | Year over year | 44.9% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -4,950.4% 2018
Net margin -19.5% 2025
Free cash flow margin -16.7% 2023
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -507.4% |
|
| 2017 | Operating margin | -47,911.7% |
|
| 2018 | Operating margin | -4,950.4% |
|
| 2019-12-31 | Operating margin | Not reported |
|
| 2020-12-31 | Operating margin | Not reported |
|
| 2021-12-31 | Operating margin | Not reported |
|
| 2022-12-31 | Operating margin | Not reported |
|
| 2023-12-31 | Operating margin | Not reported |
|
| 2024-12-31 | Operating margin | Not reported |
|
| 2025-12-31 | Operating margin | Not reported |
|
| 2016 | Net margin | -2,071.2% |
|
| 2017 | Net margin | -46,838.6% |
|
| 2018 | Net margin | -4,959.7% |
|
| 2019 | Net margin | 84.6% |
|
| 2020 | Net margin | -198.3% |
|
| 2021 | Net margin | -118.5% |
|
| 2022 | Net margin | -43.7% |
|
| 2023 | Net margin | -99.5% |
|
| 2024 | Net margin | -27% |
|
| 2025 | Net margin | -19.5% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | -234.3% |
|
| 2020 | Free cash flow margin | -146.4% |
|
| 2021 | Free cash flow margin | -53.8% |
|
| 2022 | Free cash flow margin | -17.7% |
|
| 2023 | Free cash flow margin | -16.7% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 165.5K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | Not reported | No source recorded |
| 2017 | Operating cash flow | -672227 |
|
| 2018 | Operating cash flow | -328751 |
|
| 2019 | Operating cash flow | -1730788 |
|
| 2020 | Operating cash flow | -1902758 |
|
| 2021 | Operating cash flow | -901298 |
|
| 2022 | Operating cash flow | -390621 |
|
| 2023 | Operating cash flow | -415749 |
|
| 2024 | Operating cash flow | 281968 |
|
| 2025 | Operating cash flow | 165520 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -415.7K 2023
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable | No source recorded |
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | -1753773 |
|
| 2020 | Free cash flow | -1902758 |
|
| 2021 | Free cash flow | -901298 |
|
| 2022 | Free cash flow | -398608 |
|
| 2023 | Free cash flow | -415749 |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
13.6% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 1,714% |
|
| 2017 | Liabilities / assets | 205% |
|
| 2018 | Liabilities / assets | 4,255.6% |
|
| 2019 | Liabilities / assets | 125.1% |
|
| 2020 | Liabilities / assets | 8.4% |
|
| 2021-12-31 | Liabilities / assets | Not reported |
|
| 2022-12-31 | Liabilities / assets | Not reported |
|
| 2023-12-31 | Liabilities / assets | Not reported |
|
| 2024 | Liabilities / assets | 82.7% |
|
| 2025 | Liabilities / assets | 13.6% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.75× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 0.06× |
|
| 2017 | Current assets / current liabilities | 0.06× |
|
| 2018 | Current assets / current liabilities | 0× |
|
| 2019 | Current assets / current liabilities | 0.75× |
|
| 2020 | Current assets / current liabilities | 9.52× |
|
| 2021 | Current assets / current liabilities | 4.14× |
|
| 2022 | Current assets / current liabilities | 2.26× |
|
| 2023 | Current assets / current liabilities | 1.13× |
|
| 2024 | Current assets / current liabilities | 1.24× |
|
| 2025 | Current assets / current liabilities | 0.75× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | −USD 3.56 million Exact valueExact value: -3562075 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 672,227 Exact valueExact value: -672227 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −USD 3.33 million Exact valueExact value: -3329517 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 328,751 Exact valueExact value: -328751 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | USD 632,776 Exact valueExact value: 632776 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.73 million Exact valueExact value: -1730788 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 22,985 Exact valueExact value: 22985 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.75 million Calculation and evidence-1730788 − 22985 USD Exact free cash flow: -1753773 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 2.58 million Exact valueExact value: -2576375 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.9 million Exact valueExact value: -1902758 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.9 million Calculation and evidence-1902758 − 0 USD Exact free cash flow: -1902758 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 1.99 million Exact valueExact value: -1987122 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 901,298 Exact valueExact value: -901298 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 901,298 Calculation and evidence-901298 − 0 USD Exact free cash flow: -901298 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 983,121 Exact valueExact value: -983121 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 390,621 Exact valueExact value: -390621 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7,987 Exact valueExact value: 7987 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 398,608 Calculation and evidence-390621 − 7987 USD Exact free cash flow: -398608 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 2.47 million Exact valueExact value: -2472931 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 415,749 Exact valueExact value: -415749 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 415,749 Calculation and evidence-415749 − 0 USD Exact free cash flow: -415749 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 840,671 Exact valueExact value: -840671 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 281,968 Exact valueExact value: 281968 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-07-01 – 2025-06-30 | −USD 331,739 Exact valueExact value: -331739 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 881,119 Exact valueExact value: -881119 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 165,520 Exact valueExact value: 165520 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
59 filings · 2,588 latest values · 2,588 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001630176, 1630176, HYEX, edgar:1630176, grck
Also known as GREY CLOAK TECH INC., HEALTHLY EXTRACTS INC., HEALTHY EXTRACTS INC., Healthy Extracts Inc., Healthy Extracts, Inc.